BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Testicular cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Diagnosis
61 results:

  • 1. cancer incidence in the US military: An updated analysis.
    Bytnar JA; McGlynn KA; Nealeigh MD; Shriver CD; Zhu K
    Cancer; 2024 Jan; 130(1):96-106. PubMed ID: 37725334
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Predictive factors of diagnostic delay and effect on treatment patterns in testicular germ cell tumor patients.
    Badia RR; Chertack N; Meng X; Howard J; Singla N; Margulis V; Lotan Y; Woldu S; Bagrodia A
    Urol Oncol; 2022 May; 40(5):201.e1-201.e7. PubMed ID: 35400569
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comparison of the Prognostic Outcome between High-Grade Ovarian Sertoli-Leydig Cell Tumors (SLCTs) and Low-Grade SLCTs.
    Eoh KJ; Park J; Kim HM; Lee M; Kim YT
    Yonsei Med J; 2021 Apr; 62(4):366-369. PubMed ID: 33779091
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Assessment of Age and Duration of Symptoms on Outcomes of Emergency Scrotal Exploration for Acute Scrotal Pain.
    Nandwani GM; Anwar A; Singh R; Stewart AB; Forster JA; Addla SK
    J Coll Physicians Surg Pak; 2020 Feb; 30(2):201-204. PubMed ID: 32036831
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Centralization tendencies of retroperitoneal lymph node dissection for testicular cancer in Germany? A total population-based analysis from 2006 to 2015.
    Groeben C; Koch R; Nestler T; Kraywinkel K; Borkowetz A; Wenzel S; Baunacke M; Thomas C; Huber J
    World J Urol; 2020 Jul; 38(7):1765-1772. PubMed ID: 31605195
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Risk of Gynecomastia with Users of Proton Pump Inhibitors.
    He B; Carleton B; Etminan M
    Pharmacotherapy; 2019 May; 39(5):614-618. PubMed ID: 30865318
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult cancer Survivor Study): a population-based, cohort study.
    Bright CJ; Reulen RC; Winter DL; Stark DP; McCabe MG; Edgar AB; Frobisher C; Hawkins MM
    Lancet Oncol; 2019 Apr; 20(4):531-545. PubMed ID: 30797674
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Is follow-up ultrasound necessary after acute epididymitis? A retrospective analysis from a large university hospital.
    Capet J; Sønsksen J; Bisbjerg R; Fode M
    Scand J Urol; 2018; 52(5-6):445-447. PubMed ID: 30600755
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Incidence and diagnoses of disorders of sex development in proximal hypospadias.
    Wong YS; Tam YH; Pang KKY; Yau HC
    J Pediatr Surg; 2018 Dec; 53(12):2498-2501. PubMed ID: 30224237
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Assessing the feasibility and validity of the Toronto Childhood cancer Stage Guidelines: a population-based registry study.
    Aitken JF; Youlden DR; Moore AS; Baade PD; Ward LJ; Thursfield VJ; Valery PC; Green AC; Gupta S; Frazier AL
    Lancet Child Adolesc Health; 2018 Mar; 2(3):173-179. PubMed ID: 30169253
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Late Relapse of testicular cancer at the Pelvis with Elevated AFP Levels : A Case Report].
    Shimada S; Kinoshita H; Yoshida T; Takayasu K; Mishima T; Yoshida K; Yanishi M; Inui H; Sugi M; Matsuda T
    Hinyokika Kiyo; 2018 Mar; 64(3):131-134. PubMed ID: 29684964
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Variation in 'fast-track' referrals for suspected cancer by patient characteristic and cancer diagnosis: evidence from 670 000 patients with cancers of 35 different sites.
    Zhou Y; Mendonca SC; Abel GA; Hamilton W; Walter FM; Johnson S; Shelton J; Elliss-Brookes L; McPhail S; Lyratzopoulos G
    Br J Cancer; 2018 Jan; 118(1):24-31. PubMed ID: 29182609
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Diabetes mellitus and optic atrophy: study of the Wolfram syndrome].
    Rivas-Gómez B; Reza-Albarrán AA
    Gac Med Mex; 2017; 153(4):466-472. PubMed ID: 28991271
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Extending traceability of malignant testicular tumours using hospital discharge records: an experience in Veneto Region (Northern Italy)].
    Saugo M; Mastrangelo G; Blengio G; Righetto G
    Epidemiol Prev; 2017; 41(3-4):184-186. PubMed ID: 28929714
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Non-palpable incidentally found testicular tumors: Differentiation between benign, malignant, and burned-out tumors using dynamic contrast-enhanced MRI.
    El Sanharawi I; Correas JM; Glas L; Ferlicot S; Izard V; Ducot B; Bellin MF; Benoît G; Rocher L
    Eur J Radiol; 2016 Nov; 85(11):2072-2082. PubMed ID: 27776661
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Evolving patterns of care in the management of stage I non-seminomatous germ cell tumors: data from the California cancer Registry.
    Yap SA; Yuh LM; Evans CP; Dall'Era MA; Wagenaar RM; Cress R; Lara PN
    World J Urol; 2017 Feb; 35(2):277-283. PubMed ID: 27306686
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Treatment Trends for Stage I testicular Seminoma in an Equal-Access Medical System.
    Wingate JT; Etzioni R; Macdonald DM; Brand TC
    Clin Genitourin Cancer; 2016 Oct; 14(5):438-443. PubMed ID: 26794393
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer.
    Oldenburg J; Aparicio J; Beyer J; Cohn-Cedermark G; Cullen M; Gilligan T; De Giorgi U; De Santis M; de Wit R; Fosså SD; Germà-Lluch JR; Gillessen S; Haugnes HS; Honecker F; Horwich A; Lorch A; Ondruš D; Rosti G; Stephenson AJ; Tandstad T
    Ann Oncol; 2015 May; 26(5):833-838. PubMed ID: 25378299
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Differential diagnosis of nonpalpable testicular lesions: qualitative and quantitative contrast-enhanced US of benign and malignant testicular tumors.
    Isidori AM; Pozza C; Gianfrilli D; Giannetta E; Lemma A; Pofi R; Barbagallo F; Manganaro L; Martino G; Lombardo F; Cantisani V; Franco G; Lenzi A
    Radiology; 2014 Nov; 273(2):606-18. PubMed ID: 24968192
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Risk factors for loss to follow-up during active surveillance of patients with Stage I seminoma.
    Endo T; Kawai K; Kamba T; Inai H; Uchida K; Miyazaki J; Kamoto T; Ogawa O; Nishiyama H
    Jpn J Clin Oncol; 2014 Apr; 44(4):355-9. PubMed ID: 24558127
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.